194 related articles for article (PubMed ID: 34711413)
1. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma.
Salimian KJ; Birkness-Gartman J; Waters KM
Pathology; 2022 Mar; 54(2):147-156. PubMed ID: 34711413
[TBL] [Abstract][Full Text] [Related]
2. [Topic complex I: Definitions, epidemiology and natural course].
Schepp W; Allescher HD; Frieling T; Katschinski M; Malfertheiner P; Pehl C; Peitz U; Rösch W; Hotz J
Z Gastroenterol; 2005 Feb; 43(2):165-8. PubMed ID: 15700207
[No Abstract] [Full Text] [Related]
3. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
[TBL] [Abstract][Full Text] [Related]
4. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
5. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
Royston C; Bardhan KD
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
[TBL] [Abstract][Full Text] [Related]
6. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
7. [Barrett's esophagus: diagnosis and therapy].
Schmassmann A; Gebbers JO
Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
[TBL] [Abstract][Full Text] [Related]
8. Oesophageal adenocarcinoma and Barrett's oesophagus.
Das M
Lancet Oncol; 2016 Dec; 17(12):e524. PubMed ID: 27818151
[No Abstract] [Full Text] [Related]
9. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience.
Chen MJ; Lee YC; Chiu HM; Wu MS; Wang HP; Lin JT
Dis Esophagus; 2010 Apr; 23(3):201-7. PubMed ID: 19788438
[TBL] [Abstract][Full Text] [Related]
10. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
11. Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma.
Kavanagh ME; Conroy MJ; Clarke NE; Gilmartin NT; O'Sullivan KE; Feighery R; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; O'Sullivan J; Lysaght J
Cancer Lett; 2016 Jan; 370(1):117-24. PubMed ID: 26519754
[TBL] [Abstract][Full Text] [Related]
12. Oesophageal acid exposure: higher in Barrett's oesophagus than in reflux oesophagitis.
Salminen JT; Tuominen JA; Rämö OJ; Färkkilä MA; Salo JA
Ann Med; 1999 Feb; 31(1):46-50. PubMed ID: 10219713
[TBL] [Abstract][Full Text] [Related]
13. Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective.
Fitzgerald RC
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():45-9. PubMed ID: 15575873
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma.
Denver P; Donnelly M; Murray LJ; Anderson LA
World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction.
Grillo F; Mastracci L; Saragoni L; Vanoli A; Limarzi F; Gullo I; Ferro J; Paudice M; Parente P; Fassan M
Pathologica; 2020 Sep; 112(3):138-152. PubMed ID: 33179618
[TBL] [Abstract][Full Text] [Related]
16. Short Barrett: prevalence and risk factors.
de Mas CR; Krämer M; Seifert E; Rippin G; Vieth M; Stolte M
Scand J Gastroenterol; 1999 Nov; 34(11):1065-70. PubMed ID: 10582754
[TBL] [Abstract][Full Text] [Related]
17. Oesophageal adenocarcinoma.
van Lanschot JJ
Best Pract Res Clin Gastroenterol; 2006; 20(5):801-2. PubMed ID: 16997161
[No Abstract] [Full Text] [Related]
18. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
[TBL] [Abstract][Full Text] [Related]
19. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
[TBL] [Abstract][Full Text] [Related]
20. Oesophageal disease: gastroesophageal reflux disease, Barrett's oesophagus, achalasia and eosinophilic oesophagitis.
Calvet X
Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():47-52. PubMed ID: 27888864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
